Scalp block versus general anesthesia for burr‑hole evacuation of subdural hematoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with subdural hematoma who meet eligibility criteria will be assigned to receive either a scalp block (local anesthetic) or standard general anesthesia (including cisatracurium for muscle relaxation) for burr‑hole evacuation. The study will compare intraoperative stability, postoperative pain control, immediate complications, and early recovery measures between the two approaches. Key inclusion criteria include age 18–75, ASA II–III, and GCS ≥8, while patients with coagulopathy, local infection, significant heart block, or known drug sensitivity are excluded. The procedure and assessments are conducted at a single center (Sohag University Hospital).

Why it matters

Who can join: the full rules

Inclusion Criteria

* Age from 18 to 75 years old.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status II-III.
* Patients with subdural hematoma undergoing burr-hole evacuation

Exclusion Criteria:

* Patients with a history of known sensitivity to study drugs.
* Glasgow Coma Scale (GCS) \<8
* Impaired coagulation profile.
* Any degree of heart block.
* Infection at site of injection

Where it's running

• Sohag university hospital
  Sohag, Egypt Recruiting

Study contacts

• Study coordinator: Mohamed H elsayed, Resident
• Email: sakr422022@gmail.com
• Phone: 01050053614

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma

  A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07656818

• MMA Embolization with NeoCast for Subacute and Chronic Subdural Hematoma

  This trial tests whether the NeoCast Embolic System safely and effectively works to treat subacute or chronic subdural hematomas after surgery, compared with the Onyx liquid embolic.

  Recruiting Arsenal Medical, Inc. · New Haven, Connecticut and 1 other locations · NCT07541404

• Histoacryl glue embolization of the middle meningeal artery for chronic subdural hematoma (HARMONY)

  This study tests whether injecting Histoacryl glue into the middle meningeal artery can prevent recurrence or worsening of chronic subdural hematoma in adults.

  Recruiting at 3 sites Aesculap AG · Fukuoka, Kitakyushu-city and 5 other locations · NCT07258069

• Evaluating outcomes in neurosurgery using standardized measures

  This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.

  Recruiting at 11 sites Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Bergamo, BG and 26 other locations · NCT06724029

• Using tranexamic acid to help people with symptomatic subdural hematoma

  This trial tests whether tranexamic acid can help reduce bleeding and speed recovery in adults 45 and older with symptomatic subdural hematoma.

  Recruiting Phase 3 Unity Health Toronto · Toronto, Ontario · NCT05713630

• Evaluating a new method for draining fluid and blood in brain hemorrhages

  This study is testing a new device for draining fluid and blood from the brain to see if it works better than the standard method for patients with brain hemorrhages.

  Recruiting Ohio State University · Columbus, Ohio · NCT05649904

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.